Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Safety and Efficacy of Universal Postoperative Decolonization for Kidney Transplant Recipients.

Lee DH, Malat G, Boyle SM, Talluri S, Bias TE, Harhay MN, Ranganna K, Doyle A.

Exp Clin Transplant. 2019 Jul 2. doi: 10.6002/ect.2018.0341. [Epub ahead of print]

2.

Association Between Weight Loss Before Deceased Donor Kidney Transplantation and Posttransplantation Outcomes.

Harhay MN, Ranganna K, Boyle SM, Brown AM, Bajakian T, Levin Mizrahi LB, Xiao G, Guy S, Malat G, Segev DL, Reich D, McAdams-DeMarco M.

Am J Kidney Dis. 2019 Sep;74(3):361-372. doi: 10.1053/j.ajkd.2019.03.418. Epub 2019 May 21.

PMID:
31126666
3.

Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.

Smith GP, Jain-Gupta N, Alqublan H, Dorneles EMS, Boyle SM, Sriranganathan N.

Vaccine. 2019 Feb 8;37(7):910-914. doi: 10.1016/j.vaccine.2018.12.070. Epub 2019 Jan 14.

PMID:
30655173
4.

Association of the kidney allocation system with dialysis exposure before deceased donor kidney transplantation by preemptive wait-listing status.

Harhay MN, Harhay MO, Ranganna K, Boyle SM, Levin Mizrahi L, Guy S, Malat GE, Xiao G, Reich DJ, Patzer RE.

Clin Transplant. 2018 Oct;32(10):e13386. doi: 10.1111/ctr.13386. Epub 2018 Sep 15.

5.

Association between Medicaid Expansion under the Affordable Care Act and Preemptive Listings for Kidney Transplantation.

Harhay MN, McKenna RM, Boyle SM, Ranganna K, Mizrahi LL, Guy S, Malat GE, Xiao G, Reich DJ, Harhay MO.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1069-1078. doi: 10.2215/CJN.00100118. Epub 2018 Jun 21.

6.

Kidney Transplantation in HIV-Positive Patients: A Single-Center, 16-Year Experience.

Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, Lee DH, Ranganna KM, Anil Kumar MS, Doyle AM.

Am J Kidney Dis. 2019 Jan;73(1):112-118. doi: 10.1053/j.ajkd.2018.02.352. Epub 2018 Apr 25.

PMID:
29705074
7.

Barriers to listing for HIV-infected patients being evaluated for kidney transplantation.

Lee DH, Boyle SM, Malat GE, Kern C, Milrod C, DeBellis S, Harhay MN, Ranganna K, Guy S, Talluri S, Bias T, Doyle A.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12777. Epub 2017 Oct 5.

8.

Donor-Derived Metastatic Melanoma and Checkpoint Inhibition.

Boyle SM, Ali N, Olszanski AJ, Park DJ, Xiao G, Guy S, Doyle AM.

Transplant Proc. 2017 Sep;49(7):1551-1554. doi: 10.1016/j.transproceed.2017.06.007.

PMID:
28838438
9.

HIV in the dialysis population: Current issues and future directions.

Boyle SM, Lee DH, Wyatt CM.

Semin Dial. 2017 Sep;30(5):430-437. doi: 10.1111/sdi.12615. Epub 2017 Jun 13. Review.

PMID:
28608994
10.

Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients.

Boyle SM, Malat G, Harhay MN, Lee DH, Pang L, Talluri S, Sharma A, Bias TE, Ranganna K, Doyle AM.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12727. Epub 2017 Jul 28.

PMID:
28520146
12.

Correction: Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.

Ojo KK, Ranade RM, Zhang Z, Dranow DM, Myers JB, Choi R, Nakazawa Hewitt S, Edwards TE, Davies DR, Lorimer D, Boyle SM, Barrett LK, Buckner FS, Fan E, Van Voorhis WC.

PLoS One. 2016 Sep 22;11(9):e0163641. doi: 10.1371/journal.pone.0163641. eCollection 2016.

13.

Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.

Ojo KK, Ranade RM, Zhang Z, Dranow DM, Myers JB, Choi R, Nakazawa Hewitt S, Edwards TE, Davies DR, Lorimer D, Boyle SM, Barrett LK, Buckner FS, Fan E, Van Voorhis WC.

PLoS One. 2016 Aug 8;11(8):e0160350. doi: 10.1371/journal.pone.0160350. eCollection 2016. Erratum in: PLoS One. 2016;11(9):e0163641.

14.

Vaccination of Elk (Cervus canadensis) with Brucella abortus Strain RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes Does Not Induce Adequate Protection against Experimental Brucella abortus Challenge.

Nol P, Olsen SC, Rhyan JC, Sriranganathan N, McCollum MP, Hennager SG, Pavuk AA, Sprino PJ, Boyle SM, Berrier RJ, Salman MD.

Front Cell Infect Microbiol. 2016 Feb 10;6:10. doi: 10.3389/fcimb.2016.00010. eCollection 2016.

15.

Short-term memory trace mediated by termination kinetics of olfactory receptor.

Boyle SM, McInally S, Tharadra S, Ray A.

Sci Rep. 2016 Feb 1;6:19863. doi: 10.1038/srep19863.

16.

The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study.

Wahab R, Yip NH, Chandra S, Nguyen M, Pavlovich KH, Benson T, Vilotijevic D, Rodier DM, Patel KR, Rychcik P, Perez-Mir E, Boyle SM, Berlin D, Needham DM, Brodie D.

J Intensive Care Soc. 2016 Feb;17(1):2-11. doi: 10.1177/1751143715605118. Epub 2015 Sep 21.

17.

Low rates of vaccination in listed kidney transplant candidates.

Lee DH, Boyle SM, Malat G, Sharma A, Bias T, Doyle AM.

Transpl Infect Dis. 2016 Feb;18(1):155-9. doi: 10.1111/tid.12473. Epub 2016 Jan 30.

PMID:
26461052
18.

Management of the Dialysis Patient with Sickle Cell Disease.

Boyle SM, Jacobs B, Sayani FA, Hoffman B.

Semin Dial. 2016 Jan-Feb;29(1):62-70. doi: 10.1111/sdi.12403. Epub 2015 Jul 14. Review.

PMID:
26174870
19.

Antidiabetic Therapy in End-Stage Renal Disease.

Boyle SM, Simon B, Kobrin SM.

Semin Dial. 2015 Jul-Aug;28(4):337-44. doi: 10.1111/sdi.12368. Epub 2015 Apr 21. Review.

PMID:
25898790
20.

Erythropoietin and resistant hypertension in CKD.

Boyle SM, Berns JS.

Semin Nephrol. 2014;34(5):540-9. doi: 10.1016/j.semnephrol.2014.08.008. Review.

PMID:
25416663
21.

Roles of bacterial membrane vesicles.

Avila-Calderón ED, Araiza-Villanueva MG, Cancino-Diaz JC, López-Villegas EO, Sriranganathan N, Boyle SM, Contreras-Rodríguez A.

Arch Microbiol. 2015 Jan;197(1):1-10. doi: 10.1007/s00203-014-1042-7. Epub 2014 Oct 8. Review.

PMID:
25294190
22.

Proteomic analysis of detergent resistant membrane domains during early interaction of macrophages with rough and smooth Brucella melitensis.

Lauer SA, Iyer S, Sanchez T, Forst CV, Bowden B, Carlson K, Sriranganathan N, Boyle SM.

PLoS One. 2014 Mar 18;9(3):e91706. doi: 10.1371/journal.pone.0091706. eCollection 2014.

23.

Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model.

Jain-Gupta N, Contreras-Rodriguez A, Smith GP, Garg VK, Witonsky SG, Isloor S, Vemulapalli R, Boyle SM, Sriranganathan N.

Vaccine. 2014 Feb 12;32(8):918-23. doi: 10.1016/j.vaccine.2013.12.058. Epub 2014 Jan 4.

PMID:
24397905
24.

Targeting a dual detector of skin and CO2 to modify mosquito host seeking.

Tauxe GM, MacWilliam D, Boyle SM, Guda T, Ray A.

Cell. 2013 Dec 5;155(6):1365-79. doi: 10.1016/j.cell.2013.11.013.

25.

PATH-SCAN: a reporting tool for identifying clinically actionable variants.

Daneshjou R, Zappala Z, Kukurba K, Boyle SM, Ormond KE, Klein TE, Snyder M, Bustamante CD, Altman RB, Montgomery SB.

Pac Symp Biocomput. 2014:229-40.

26.

Expanding the olfactory code by in silico decoding of odor-receptor chemical space.

Boyle SM, McInally S, Ray A.

Elife. 2013 Oct 1;2:e01120. doi: 10.7554/eLife.01120.

27.

Odour receptors and neurons for DEET and new insect repellents.

Kain P, Boyle SM, Tharadra SK, Guda T, Pham C, Dahanukar A, Ray A.

Nature. 2013 Oct 24;502(7472):507-12. doi: 10.1038/nature12594. Epub 2013 Oct 2. Retraction in: Nature. 2016 Aug 25;536(7617):488.

28.

A legacy of data use by Donna Diers.

Birmingham SE, Boyle SM.

Nurs Econ. 2013 May-Jun;31(3):144-5, 154.

PMID:
23923243
29.

A review of Brucella seroprevalence among humans and animals in Bangladesh with special emphasis on epidemiology, risk factors and control opportunities.

Islam MA, Khatun MM, Werre SR, Sriranganathan N, Boyle SM.

Vet Microbiol. 2013 Oct 25;166(3-4):317-26. doi: 10.1016/j.vetmic.2013.06.014. Epub 2013 Jun 29. Review.

PMID:
23867082
30.

A history of the development of Brucella vaccines.

Avila-Calderón ED, Lopez-Merino A, Sriranganathan N, Boyle SM, Contreras-Rodríguez A.

Biomed Res Int. 2013;2013:743509. doi: 10.1155/2013/743509. Epub 2013 Jun 3. Review.

31.

Protection to respiratory challenge of Brucella abortus strain 2308 in the lung.

Surendran N, Sriranganathan N, Boyle SM, Hiltbold EM, Tenpenny N, Walker M, Zimmerman K, Werre S, Witonsky SG.

Vaccine. 2013 Aug 28;31(38):4103-10. doi: 10.1016/j.vaccine.2013.06.078. Epub 2013 Jul 8.

PMID:
23845817
32.

Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages.

Rajasekaran P, Alexander JC, Seleem MN, Jain N, Sriranganathan N, Wattam AR, Setubal JC, Boyle SM.

Int J Antimicrob Agents. 2013 Apr;41(4):358-62. doi: 10.1016/j.ijantimicag.2012.11.017. Epub 2013 Jan 8.

33.

Acute care nurses' spiritual care practices.

Gallison BS, Xu Y, Jurgens CY, Boyle SM.

J Holist Nurs. 2013 Jun;31(2):95-103. doi: 10.1177/0898010112464121. Epub 2012 Nov 21.

PMID:
23175168
34.

Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Jain-Gupta N, Contreras-Rodriguez A, Vemulapalli R, Witonsky SG, Boyle SM, Sriranganathan N.

FEMS Immunol Med Microbiol. 2012 Dec;66(3):436-44. doi: 10.1111/1574-695X.12010.

35.

Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.

Wattam AR, Inzana TJ, Williams KP, Mane SP, Shukla M, Almeida NF, Dickerman AW, Mason S, Moriyón I, O'Callaghan D, Whatmore AM, Sobral BW, Tiller RV, Hoffmaster AR, Frace MA, De Castro C, Molinaro A, Boyle SM, De BK, Setubal JC.

MBio. 2012 Nov 6;3(5):e00246-11. doi: 10.1128/mBio.00388-12.

36.

Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.

Wattam AR, Inzana TJ, Williams KP, Mane SP, Shukla M, Almeida NF, Dickerman AW, Mason S, Moriyón I, O'Callaghan D, Whatmore AM, Sobral BW, Tiller RV, Hoffmaster AR, Frace MA, De Castro C, Molinaro A, Boyle SM, De BK, Setubal JC.

MBio. 2012 Aug 28;3(5):e00246-12. doi: 10.1128/mBio.00246-12. Print 2012. Erratum in: MBio. 2012 Nov-Dec;3(6):e00388-12.

37.

Effect of exogenous erythritol on growth and survival of Brucella.

Jain N, Boyle SM, Sriranganathan N.

Vet Microbiol. 2012 Dec 7;160(3-4):513-6. doi: 10.1016/j.vetmic.2012.06.014. Epub 2012 Jun 20.

PMID:
22784921
38.

Nanomedicine for intracellular therapy.

Ranjan A, Pothayee N, Seleem MN, Boyle SM, Kasimanickam R, Riffle JS, Sriranganathan N.

FEMS Microbiol Lett. 2012 Jul;332(1):1-9. doi: 10.1111/j.1574-6968.2012.02566.x. Epub 2012 May 3. Review.

39.

The first detection of Brucella canis in cattle in the Republic of Korea.

Baek BK, Park MY, Islam MA, Khatun MM, Lee SI, Boyle SM.

Zoonoses Public Health. 2012 Mar;59(2):77-82. doi: 10.1111/j.1863-2378.2011.01429.x. Epub 2011 Aug 21.

PMID:
22339983
40.

Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.

Avila-Calderón ED, Lopez-Merino A, Jain N, Peralta H, López-Villegas EO, Sriranganathan N, Boyle SM, Witonsky S, Contreras-Rodríguez A.

Clin Dev Immunol. 2012;2012:352493. doi: 10.1155/2012/352493. Epub 2011 Dec 29.

41.

Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo.

Surendran N, Hiltbold EM, Heid B, Akira S, Standiford TJ, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vaccine. 2012 Feb 14;30(8):1502-12. doi: 10.1016/j.vaccine.2011.12.036. Epub 2012 Jan 9.

PMID:
22234268
42.

Closing the RN engagement gap: which drivers of engagement matter?

Rivera RR, Fitzpatrick JJ, Boyle SM.

J Nurs Adm. 2011 Jun;41(6):265-72. doi: 10.1097/NNA.0b013e31821c476c.

PMID:
21610481
43.

Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain.

Chen F, Ding X, Ding Y, Xiang Z, Li X, Ghosh D, Schurig GG, Sriranganathan N, Boyle SM, He Y.

Infect Immun. 2011 Jun;79(6):2460-9. doi: 10.1128/IAI.00050-11. Epub 2011 Apr 4.

44.

Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.

Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.

Vaccine. 2011 Apr 12;29(17):3106-10. doi: 10.1016/j.vaccine.2011.02.054. Epub 2011 Mar 3.

PMID:
21376799
45.

Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.

Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.

Vaccine. 2011 Mar 24;29(15):2749-55. doi: 10.1016/j.vaccine.2011.01.090. Epub 2011 Feb 20.

PMID:
21316499
46.

Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308.

Jain N, Rodriguez AC, Kimsawatde G, Seleem MN, Boyle SM, Sriranganathan N.

FEMS Microbiol Lett. 2011 Mar;316(1):1-6. doi: 10.1111/j.1574-6968.2010.02186.x. Epub 2011 Jan 10.

47.

Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Witonsky SG.

FEMS Immunol Med Microbiol. 2010 Nov;60(2):147-55. doi: 10.1111/j.1574-695X.2010.00729.x. Epub 2010 Aug 31.

48.

Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.

Surendran N, Zimmerman K, Seleem MN, Sriranganathan N, Boyle SM, Hiltbold EM, Lawler H, Heid B, Witonsky SG.

Vaccine. 2010 Oct 8;28(43):7009-15. doi: 10.1016/j.vaccine.2010.08.039. Epub 2010 Aug 18.

PMID:
20727395
49.

Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vet Microbiol. 2011 Jan 10;147(1-2):75-82. doi: 10.1016/j.vetmic.2010.06.001. Epub 2010 Jun 10.

PMID:
20594772
50.

Tightly regulated expression vectors for Ochrobactrum anthropi.

Alqublan H, Seleem MN, Boyle SM, Sriranganathan N.

Curr Microbiol. 2010 Apr;60(4):242-7. doi: 10.1007/s00284-009-9532-6. Epub 2010 Mar 17.

PMID:
20237980

Supplemental Content

Loading ...
Support Center